Jefferies Group’s Dynavax Technologies DVAX Stock Holding History

Jefferies Group’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$235K	Hold	22,500	–	–	﹤0.01%	1319
2022 Q2	$283K	Buy	+22,500	New	+$239K	﹤0.01%	1185
2022 Q1	–	Sell	-10,000	Closed	-$141K	–	1619
2021 Q4	$141K	Hold	10,000	–	–	﹤0.01%	1440
2021 Q3	$192K	Hold	10,000	–	–	﹤0.01%	1469
2021 Q2	$98.5K	Hold	10,000	–	–	﹤0.01%	1490
2021 Q1	$98.3K	Buy	+10,000	New	+$82.4K	﹤0.01%	1445
2020 Q3	–	Sell	-50,000	Closed	-$444	–	1389
2020 Q2	$444	Hold	50,000	–	–	0.01%	932
2020 Q1	$177K	Hold	50,000	–	–	﹤0.01%	1703
2019 Q4	$286K	Buy	+50,000	New	+$267K	﹤0.01%	2082
2018 Q1	–	Sell	-20,000	Closed	-$374K	–	2328
2017 Q4	$374K	Hold	20,000	–	–	﹤0.01%	1892
2017 Q3	$430K	Buy	+20,000	New	+$316K	﹤0.01%	1708

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Group's DVAX Position: Q3 2022 in Review

Jefferies Group increased its Dynavax Technologies (DVAX) stake by 1,175% in Q3 2022, buying an estimated $75K and bringing the position to 6,246 shares worth $65.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

Jefferies Group first reported a position in DVAX in Q2 2015 and has held it in 16 quarters since. The position peaked at $219K in Q3 2021. 236 funds tracked by Wall St. Rank hold DVAX as of Q3 2022.

Jefferies Group held 6,246 shares of Dynavax Technologies worth $65.2K as of Q3 2022.
Jefferies Group bought 5,756 Dynavax Technologies shares in Q3 2022, an estimated $75K.
Dynavax Technologies made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1498 holding.
Jefferies Group first reported a position in Dynavax Technologies in Q2 2015 and has held it in 16 quarters since.
Jefferies Group's Dynavax Technologies position peaked at $219K in Q3 2021.
236 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.